Why geneticists stole cancer research even though cancer is primarily a signaling disease-Reference-Cited by-同舟云学术

Why geneticists stole cancer research even though cancer is primarily a signaling disease

Published:2019-01-22 Issue:565 Volume:12 Page:
ISSN:1945-0877
Container-title:Science Signaling
language:en
Short-container-title:Sci. Signal.

Author:

Yaffe Michael B.¹²^ORCID

Affiliation:

1. Chief Scientific Advisor and Academic Editor, Science Signaling, American Association for the Advancement of Science, Washington, DC 20005, USA.

2. David H. Koch Institute for Integrative Cancer Research, MIT Center for Precision Cancer Medicine, Broad Institute, and the Departments of Biology and Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.

Abstract

Technological advances in protein detection will enable breakthroughs in precision cancer medicine.

Funder

NIH Office of the Director

Ovarian Cancer Research Fund

MIT Center for Precision Cancer Medicine

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference10 articles.

1. R. A. Weinberg Racing to the Beginning of the Road: The Search for the Origin of Cancer (W. H. Freeman & Co 1996) p. 263.

2. Mutational processes shape the landscape of TP53 mutations in human cancer

3. Hallmarks of Cancer: The Next Generation

4. Illuminating the dark phosphoproteome

5. Analysis of aptamer discovery and technology

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent developments in mass-spectrometry-based targeted proteomics of clinical cancer biomarkers;Clinical Proteomics;2024-01-30

2. Functional and spatial proteomics profiling reveals intra- and intercellular signaling crosstalk in colorectal cancer;iScience;2023-12

3. Mass spectrometry-based proteomics as an emerging tool in clinical laboratories;Clinical Proteomics;2023-08-26

4. Proteomics-based clustering of lung adenocarcinoma identifies three subtypes with significantly different clinical and molecular features;Clinical and Translational Oncology;2023-08-21

5. In depth profiling of the cancer proteome from the flowthrough of standard RNA-preparation kits for precision oncology;2023-05-14